ATP-sensitive potassium (K(ATP)) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway

le Roy Chowdhury, Uttio, Bahler, Cindy K., Holman, Bradley H., Fautsch, Michael P.
Foilsithe in PLoS One (2017)

HUMAN CORNEAL ENDOTHELIAL CELL TRANSPLANTATION IN A HUMAN EX VIVO MODEL

le Patel, Sanjay V., Bachman, Lori A., Hann, Cheryl R., Bahler, Cindy K., Fautsch, Michael P.
Foilsithe 2009

Prostaglandins Increase Trabecular Meshwork Outflow Facility in Cultured Human Anterior Segments

le Bahler, Cindy K., Howell, Kyle G., Hann, Cheryl R., Fautsch, Michael P., Johnson, Douglas H.
Foilsithe 2007

Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems

le Roy Chowdhury, Uttio, Bahler, Cindy K., Holman, Bradley H., Dosa, Peter I., Fautsch, Michael P.
Foilsithe in PLoS One (2015)

Correction: Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems

le Roy Chowdhury, Uttio, Bahler, Cindy K., Holman, Bradley H., Dosa, Peter I., Fautsch, Michael P.
Foilsithe in PLoS One (2015)

Isolation and characterization of novel primary cells from the human distal outflow pathway

le Roy Chowdhury, Uttio, Bahler, Cindy K., Hann, Cheryl R., Holman, Bradley H., Fautsch, Michael P.
Foilsithe in Sci Rep (2021)

ATP-Sensitive Potassium (K(ATP)) Channel Activation Decreases Intraocular Pressure in the Anterior Chamber of the Eye

le Chowdhury, Uttio Roy, Bahler, Cindy K., Hann, Cheryl R., Chang, Minhwang, Resch, Zachary T., Romero, Michael F., Fautsch, Michael P.
Foilsithe 2011

CHARACTERIZATION OF MONOCLONAL ANTIBODIES AGAINST THE GLAUCOMA-ASSOCIATED PROTEIN MYOCILIN

le Ezzat, Mohamed-Karim, Howell, Kyle G., Bahler, Cindy K., Beito, Thomas G., Loewen, Nils, Poeschla, Eric M., Fautsch, Michael P.
Foilsithe 2008

Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure–Lowering Effects of Latanoprost

le Roddy, Gavin W., Viker, Kimberly B., Winkler, Nelson S., Bahler, Cindy K., Holman, Bradley H., Sheikh-Hamad, David, Roy Chowdhury, Uttio, Stamer, W. Daniel, Fautsch, Michael P.
Foilsithe in Invest Ophthalmol Vis Sci (2017)

Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits

le Roy Chowdhury, Uttio, Kudgus, Rachel A., Rinkoski, Tommy A., Holman, Bradley H., Bahler, Cindy K., Hann, Cheryl R., Reid, Joel M., Dosa, Peter I., Fautsch, Michael P.
Foilsithe in PLoS One (2020)

Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents

le Roy Chowdhury, Uttio, Rinkoski, Tommy A., Bahler, Cindy K., Millar, J. Cameron, Bertrand, Jacques A., Holman, Bradley H., Sherwood, Joseph M., Overby, Darryl R., Stoltz, Kristen L., Dosa, Peter I., Fautsch, Michael P.
Foilsithe in Invest Ophthalmol Vis Sci (2017)

Pharmacological Profile and Ocular Hypotensive Effects of Cromakalim Prodrug 1, a Novel ATP-Sensitive Potassium Channel Opener, in Normotensive Dogs and Nonhuman Primates

le Roy Chowdhury, Uttio, Kudgus, Rachel A., Holman, Bradley H., Rinkoski, Tommy A., Hann, Cheryl R., Bahler, Cindy K., McCloud, Eric, Appt, Susan E., Reid, Joel M., Dosa, Peter I., Fautsch, Michael P.
Foilsithe in J Ocul Pharmacol Ther (2021)